Clinical Trial Update: Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing nab-paclitaxel plus gemcitabine versus oxaliplatin with folinic acid and fluorouracil as second-line adjuvant therapy for gemcitabine-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Gemcitabine (Gemcitabine)
• Leucovorin (folinic acid) (folinic acid)
• Nab-paclitaxel (paclitaxel protein-bound)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Fudan University | Conditions: Stage ⅠA Pancreatic Cancer, Stage ⅠB Pancreatic Cancer | Phase 3 | Status: UNKNOWN